RxDoctor Payments Data

Marcus Davidson, PA

Physician Assistant · Lafayette, LANPI 1962942839

Payments from drug & device makers

$2,958in general payments, 2019–2025

Across 163 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$953
  • Lilly USA, LLC$245
  • Pfizer$204
  • Astellas Pharma US Inc$166
  • Exact Sciences$150
  • AstraZeneca$146
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,93299%
  • Other$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,958 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.

See all physician assistant providers in Louisiana

Medicare billing

Part B allowed, 2024
$77,053
Medicare patients
239
Services billed
1,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide84$95,226
TrulicityDulaglutide45$48,292
OzempicSemaglutide16$14,866
JanuviaSitagliptin Phosphate19$11,079
FarxigaDapagliflozin Propanediol18$10,242
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,767
AbrysvoRsv Vacc, Pref A And Pref B/Pf26$8,327
Fiasp FlextouchInsulin Aspart (Niacinamide)13$7,151
MyrbetriqMirabegron11$5,081
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,820
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,751
Bupropion XlBupropion Hcl36$1,713
Rosuvastatin Calcium90$1,498
Levothyroxine Sodium162$1,430
Ezetimibe27$1,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$245$143,518129 claims
Novo NordiskOzempic$56$14,86616 claims
AstraZenecaFarxiga$146$10,24218 claims
GSKTrelegy Ellipta$55$9,76712 claims
PfizerAbrysvo$204$8,32726 claims
Astellas Pharma US IncMyrbetriq$166$5,08111 claims
AbbVieSynthroid, Armour Thyroid$953$1,64032 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$67$1,430162 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 physician assistant providers in Louisiana.

Other physician assistant in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →